Coronavirus News

Additional Guidance on Medicare Coverage of COVID-19 Antibody Treatment

As we previously reported, the Centers for Medicare & Medicaid Services (CMS) announced in November that it would cover monoclonal antibody therapies approved by the Food and Drug Administration to treat COVID-19 patients. On December 9, 2020, CMS posted updates to its COVID-19 FAQs on Medicare FFS Billing about coverage and payment for monoclonal antibodies treatments and published a Therapeutics Coverage Infographic on coverage of monoclonal antibody therapies. The comprehensive source for CMS communications and instruction on monoclonal antibody therapy coverage is available here.